IMIDAZOCHINOLINE MIT IMMUNMODULIERENDEN EIGENSCHAFTEN
European patent · EP2155743 · Deleted
Register entry
- Publication number
- EP2155743
- Application number
- EP08737252
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- May 6, 2008
- Published
- Feb 24, 2010
- Granted
- Aug 29, 2012
- Deleted
- May 31, 2019
- Reason
- Annual fee unpaid
- IPC classes
- C07D 471/04 (2006.01)A61K 31/437 (2006.01)A61P 37/02 (2006.01)
- Priority
- US 916586 P 08.05.2007US 24957 P 31.01.2008
- PCT application
- PCT/GB2008/050328 06.05.2008
- PCT publication
- WO2008/135791 13.11.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 18, 2019
Deleted, fee unpaid
Published in Swissreg on 18.12.2019
- Nov 9, 2016
Transferred
- Owner
- AstraZeneca AB, 151 85 Södertälje, Sweden, Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan → SUMITOMO DAINIPPON PHARMA CO., LTD., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan
Published in Swissreg on 09.11.2016
- Aug 29, 2012
Granted
Published in Swissreg on 29.08.2012
Parties
Inventor
BONNERT, Roger, Victor
Loughborough Leicestershire LE11 5RH, GB
MCINALLY, Thomas
Loughborough Leicestershire LE11 5RH, GB
THOM, Stephen
Loughborough Leicestershire LE11 5RH, GB
WADA, Hiroki
Loughborough, Leicestershire LE11 5RH, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.